Tuesday, October 31, 2017 10:23:36 AM
This table compares Tetralogic Pharmaceuticals Corp and its competitors top-line revenue, earnings per share and valuation.
Gross Revenue EBITDA Price/Earnings Ratio
Tetralogic Pharmaceuticals Corp N/A -$21.14 million -0.03
Tetralogic Pharmaceuticals Corp Competitors $224.58 million $57.96 million -1.13
https://www.truebluetribune.com/2017/10/31/head-to-head-analysis-tetralogic-pharmaceuticals-corp-tlog-its-peers.html
Tetralogic Pharmaceuticals Corp’s competitors have higher revenue and earnings than Tetralogic Pharmaceuticals Corp. Tetralogic Pharmaceuticals Corp is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM